Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.3%. By the end of trading, Valeant Pharmaceuticals International fell $1.88 (-1.5%) to $127.19 on heavy volume. Throughout the day, 2,624,034 shares of Valeant Pharmaceuticals International exchanged hands as compared to its average daily volume of 1,726,600 shares. The stock ranged in price between $124.67-$129.06 after having opened the day at $128.88 as compared to the previous trading day's close of $129.07. Other companies within the Health Care sector that declined today were:
), down 24.8%,
), down 23.4%,
), down 11.6% and
), down 10.9%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Valeant Pharmaceuticals International has a market cap of $44.0 billion and is part of the drugs industry. Shares are up 9.9% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Valeant Pharmaceuticals International a buy, 1 analyst rates it a sell, and 2 rate it a hold.
TheStreet Ratings rates
Valeant Pharmaceuticals International
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and disappointing return on equity.
- You can view the full Valeant Pharmaceuticals International Ratings Report.
On the positive front,
), up 15.1%,
), up 14.5%,
), up 13.7% and
), up 12.7% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.